Table of contents
- Are we seeing any particular trends in relation to competition law in the pharmaceuticals sector?
- What particular challenges does the pharmaceuticals sector present in relation to competition law?
- How is the pharmaceuticals market defined for the purposes of competition law?
- Are there any significant cases or investigations on the horizon?
Article summary
Competition analysis: Brian Sher, competition partner with Nabarro LLP, considers the current trends in relation to competition law in the pharmaceuticals sector and explores the reasons behind the recent rise in competition enforcement.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial